Original Research
Published on 12 Feb 2026
First-line enfortumab vedotin-pembrolizumab versus nivolumab plus gemcitabine-cisplatin in metastatic urothelial cancer: a cost-effectiveness study
in Health Economics
- 145 views
Original Research
Published on 12 Feb 2026
in Health Economics
Policy and Practice Reviews
Published on 12 Feb 2026
in Agroecological Cropping Systems
Original Research
Published on 12 Feb 2026
in Population Health and Risk Factors of Stroke
Original Research
Published on 12 Feb 2026
in Infectious Diseases: Epidemiology and Prevention
Mini Review
Published on 12 Feb 2026
in Rheumatology
Original Research
Published on 12 Feb 2026
in Surgical Oncology
Original Research
Published on 12 Feb 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 12 Feb 2026
in Language, Culture and Diversity
Original Research
Published on 12 Feb 2026
in Clinical Toxicology
Original Research
Published on 12 Feb 2026
in Sports Management, Marketing, and Economics
Original Research
Published on 12 Feb 2026
in Human and Medical Genomics
Original Research
Published on 12 Feb 2026
in Public Mental Health
Case Report
Published on 12 Feb 2026
in Clinical Diabetes
Registered Report
Published on 12 Feb 2026
in Decision Neuroscience
Original Research
Published on 12 Feb 2026
in Bone Research
Original Research
Published on 12 Feb 2026
in Hematology